Showing 1 - 20 results of 261,092 for search '(((( a step decrease ) OR ( 10 ((a decrease) OR (_ decrease)) ))) OR ( 10 mg decrease ))*', query time: 1.63s Refine Results
  1. 1
  2. 2

    Rdh10a deficient embryos have decreased expression of RA signaling responsive genes. by Enrico D’Aniello (798447)

    Published 2015
    “…<p>(A-F) ISH for <i>cyp26a1</i>, <i>hoxb5b</i>, <i>and dhrs3a</i> expression in control sibling and Rdh10a deficient embryos. …”
  3. 3
  4. 4
  5. 5

    Long-term treatment with rapamycin results in decrease in progenitor cells. by Zhenya Lu (780517)

    Published 2015
    “…Quantitative calculation of DCX-positive cells per field in different groups. Rats treated with 1.0 and 3.0 mg/kg rapamycin demonstrated decrease in DCX-positive cells. …”
  6. 6

    Long-term treatment with rapamycin results in decrease in cellular immune factors. by Zhenya Lu (780517)

    Published 2015
    “…No obvious change was noted among different groups in Il-1β both in brain and blood (A,B). IL-2 was decreased with 1.0 and 3.0 mg/kg rapamycin treatment both in brain and blood (C, D). …”
  7. 7

    Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease. by Joshua Looker (21390948)

    Published 2025
    “…<p>Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.</p>…”
  8. 8
  9. 9
  10. 10

    Decreased ShcA expression promotes EMT in NMuMG and HaCaT cells. by Baby Periyanayaki Muthusamy (838234)

    Published 2015
    “…<p>(A) ShcA levels, assessed by immunoblotting, in NMuMG and HaCaT cells transfected with ShcA or control siRNA. siShc-a and siShc-b are ShcA siRNAs used in NMuMG cells, and siShc-c and siShc-d are used in HaCaT cells. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints. by Aeron M. Small (9617751)

    Published 2020
    “…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20